Active, Not Recruiting
Ipilimumab With or Without Nivolumab in Relapsed/Refractory cHL
NCT04938232
- Conditions
- Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Lymphoma, +9 more
- Locations
-
- University of Chicago Medicine Chicago, Illinois, United States
- Massachusetts General Hospital Boston, Massachusetts, United States
- Brigham and Women's Hospital Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States